Catalyst Pharmaceuticals (CPRX) Other Non-Current Assets (2010 - 2022)

Catalyst Pharmaceuticals (CPRX) has 13 years of Other Non-Current Assets data on file, last reported at $9000.0 in Q4 2022.

• Quarterly Other Non-Current Assets changed 0.0% year-over-year to $9000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $9000.0 (changed 0.0% YoY) and the FY2022 annual result came in at $9000.0, changed 0.0% from the prior year.
• Other Non-Current Assets steadied at $9000.0 in Q4 2022, from $9000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $9000.0 in Q4 2020 to a low of $8888.0 in Q1 2018.
• A 5-year average of $8938.4 and a median of $8888.0 in 2018 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2018 — Other Non-Current Assets changed 0.0% — and 2020, when it climbed 1.26%.
• Tracing CPRX's Other Non-Current Assets over 5 years: stood at $8888.0 in 2018, then changed by 0.0% to $8888.0 in 2019, then climbed by 1.26% to $9000.0 in 2020, then changed by 0.0% to $9000.0 in 2021, then changed by 0.0% to $9000.0 in 2022.
• The last three Other Non-Current Assets figures came in at $9000.0 (Q4 2022), $9000.0 (Q3 2022), and $9000.0 (Q2 2022), per Business Quant data.